Sebastian Schade

1.7k total citations
16 papers, 602 citations indexed

About

Sebastian Schade is a scholar working on Neurology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Sebastian Schade has authored 16 papers receiving a total of 602 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Neurology, 5 papers in Cellular and Molecular Neuroscience and 4 papers in Physiology. Recurrent topics in Sebastian Schade's work include Parkinson's Disease Mechanisms and Treatments (7 papers), Neurological disorders and treatments (5 papers) and Alzheimer's disease research and treatments (3 papers). Sebastian Schade is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (7 papers), Neurological disorders and treatments (5 papers) and Alzheimer's disease research and treatments (3 papers). Sebastian Schade collaborates with scholars based in Germany, United Kingdom and United States. Sebastian Schade's co-authors include Brit Mollenhauer, Claudia Trenkwalder, Walter Paulus, Friederike Sixel‐Döring, Andrea Antal, Jens Ebentheuer, Vera Moliadze, Michael Bartl, Roland G. Gera and Thomas Kremer and has published in prestigious journals such as Neurology, International Journal of Molecular Sciences and Movement Disorders.

In The Last Decade

Sebastian Schade

14 papers receiving 595 citations

Peers

Sebastian Schade
Raquel N. Taddei United Kingdom
Allison Dicke United States
Steven A. Gunzler United States
Hee Jin Kim South Korea
Raquel N. Taddei United Kingdom
Sebastian Schade
Citations per year, relative to Sebastian Schade Sebastian Schade (= 1×) peers Raquel N. Taddei

Countries citing papers authored by Sebastian Schade

Since Specialization
Citations

This map shows the geographic impact of Sebastian Schade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sebastian Schade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sebastian Schade more than expected).

Fields of papers citing papers by Sebastian Schade

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sebastian Schade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sebastian Schade. The network helps show where Sebastian Schade may publish in the future.

Co-authorship network of co-authors of Sebastian Schade

This figure shows the co-authorship network connecting the top 25 collaborators of Sebastian Schade. A scholar is included among the top collaborators of Sebastian Schade based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sebastian Schade. Sebastian Schade is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Xylaki, Mary, Joseph Schérer, Mohammed Dakna, et al.. (2025). Proteomic Exploration of L1CAM+-Extracellular Vesicles from Plasma of Manifest and Prodromal Parkinson’s Disease. International Journal of Molecular Sciences. 26(23). 11564–11564.
2.
Schade, Sebastian, Soumyabrata Ghosh, Alícia Garrido, et al.. (2025). Identifying individuals at-risk of developing Parkinson’s disease using a population-based recruitment strategy: The Healthy Brain Ageing Kassel Study. npj Parkinson s Disease. 11(1). 216–216.
3.
Li, Juan, Julianna J. Tomlinson, Tiago Mestre, et al.. (2025). Development of a simplified smell test to identify Parkinson’s disease using multiple cohorts, machine learning and item response theory. npj Parkinson s Disease. 11(1). 85–85. 1 indexed citations
4.
Weber, Sandrina, Carly M. Farris, Yihua Ma, et al.. (2025). Anosmia and Upper Limb Rigidity—A Potential Phenotype of Idiopathic Normal Pressure Hydrocephalus with Cerebrospinal Fluid α‐Synuclein Seeds. Movement Disorders. 40(6). 1206–1213. 2 indexed citations
5.
Bartl, Michael, Johanna Nilsson, Mohammed Dakna, et al.. (2024). Lysosomal and synaptic dysfunction markers in longitudinal cerebrospinal fluid of de novo Parkinson’s disease. npj Parkinson s Disease. 10(1). 102–102. 7 indexed citations
6.
González, Maria Camila, Nicholas J. Ashton, Dag Aarsland, et al.. (2024). Association of Plasma Amyloid, P-Tau, GFAP, and NfL With CSF, Clinical, and Cognitive Features in Patients With Dementia With Lewy Bodies. Neurology. 102(12). e209418–e209418. 22 indexed citations
7.
Concha‐Marambio, Luis, Sandrina Weber, Carly M. Farris, et al.. (2023). Accurate Detection of α‐Synuclein Seeds in Cerebrospinal Fluid from Isolated Rapid Eye Movement Sleep Behavior Disorder and Patients with Parkinson's Disease in the DeNovo Parkinson (DeNoPa) Cohort. Movement Disorders. 38(4). 567–578. 59 indexed citations
9.
Schade, Sebastian, Jochen Gaedcke, Albrecht Neeße, et al.. (2022). Cure Is Possible: Extensively Metastatic HER2-Positive Gastric Carcinoma with 5 years of Complete Remission after Therapy with the FLOT Regimen and Trastuzumab. Case Reports in Gastroenterology. 16(1). 80–88. 2 indexed citations
10.
Bartl, Michael, Mohammed Dakna, Sebastian Schade, et al.. (2022). Blood Markers of Inflammation, Neurodegeneration, and Cardiovascular Risk in Early Parkinson's Disease. Movement Disorders. 38(1). 68–81. 30 indexed citations
11.
Kruse, Niels, Roland G. Gera, Thomas Kremer, et al.. (2021). Systematic Assessment of 10 Biomarker Candidates Focusing on α‐Synuclein‐Related Disorders. Movement Disorders. 36(12). 2874–2887. 85 indexed citations
12.
Schade, Sebastian, Brit Mollenhauer, & Claudia Trenkwalder. (2020). Levodopa Equivalent Dose Conversion Factors: An Updated Proposal Including Opicapone and Safinamide. Movement Disorders Clinical Practice. 7(3). 343–345. 210 indexed citations
13.
Schade, Sebastian, et al.. (2017). Acute Levodopa Challenge Test in Patients with de novo Parkinson's Disease: Data from the DeNoPa Cohort. Movement Disorders Clinical Practice. 4(5). 755–762. 26 indexed citations
14.
Schade, Sebastian & Walter Paulus. (2015). D-Cycloserine in Neuropsychiatric Diseases: A Systematic Review. The International Journal of Neuropsychopharmacology. 19(4). pyv102–pyv102. 86 indexed citations
15.
Schade, Sebastian & Brit Mollenhauer. (2014). Biomarkers in biological fluids for dementia with Lewy bodies. Alzheimer s Research & Therapy. 6(5-8). 72–72. 27 indexed citations
16.
Schade, Sebastian, Vera Moliadze, Walter Paulus, & Andrea Antal. (2012). Modulating neuronal excitability in the motor cortex with tDCS shows moderate hemispheric asymmetry due to subjects' handedness: A pilot study. Restorative Neurology and Neuroscience. 30(3). 191–198. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026